173 related articles for article (PubMed ID: 11370816)
1. Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients.
Ribuffo D; Cavalieri L; De Vita F; Massa R; Prosperi D; Tuccimei M; Scuderi N
J Exp Clin Cancer Res; 2001 Mar; 20(1):11-5. PubMed ID: 11370816
[TBL] [Abstract][Full Text] [Related]
2. Rare clinical experiences for surgical treatment of melanoma with osseous metastases in Taiwan.
Huang KY; Wang CR; Yang RS
BMC Musculoskelet Disord; 2007 Jul; 8():70. PubMed ID: 17650346
[TBL] [Abstract][Full Text] [Related]
3. Detection of recurrent malignant melanoma with 99mTc-MIBI scintigraphy.
Alonso O; Martinez M; Mut F; Delgado L; Lago G; De Boni D; Bazzano C; Núñez M; Garcés M; Muse IM; Roca R; Touya E; Espasandín J; Priario J
Melanoma Res; 1998 Aug; 8(4):355-60. PubMed ID: 9764811
[TBL] [Abstract][Full Text] [Related]
4. Population-based validation of the National Cancer Comprehensive Network recommendations for baseline imaging workup of cutaneous melanoma.
Abdel-Rahman O
Melanoma Res; 2019 Feb; 29(1):53-58. PubMed ID: 30362976
[TBL] [Abstract][Full Text] [Related]
5. Computed tomography in the detection of abdominal metastases from malignant melanoma.
Silverman PM; Heaston DK; Korobkin M; Seigler HF
Invest Radiol; 1984; 19(4):309-12. PubMed ID: 6480308
[TBL] [Abstract][Full Text] [Related]
6. [Computed tomography evaluation of metastasis of cutaneous melanoma].
Potente G; Cantisani C; Cantisani V; Bottoni U; Calvieri S; Andreoli GM; Arduini F; Guerrisi R
Radiol Med; 2001 Apr; 101(4):275-80. PubMed ID: 11398059
[TBL] [Abstract][Full Text] [Related]
7. [Radionuclide study of cutaneous melanomas with 99m Tc-HMPAO: visualization of metastases and recurrence].
Collazo de la Maza AA; Borrón Molinos MC; Cordiés Justiz N; Pimentel González G; Sánchez Monzón I
Rev Esp Med Nucl; 1999; 18(1):16-20. PubMed ID: 10074213
[TBL] [Abstract][Full Text] [Related]
8. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients.
Machet L; Nemeth-Normand F; Giraudeau B; Perrinaud A; Tiguemounine J; Ayoub J; Alison D; Vaillant L; Lorette G
Br J Dermatol; 2005 Jan; 152(1):66-70. PubMed ID: 15656802
[TBL] [Abstract][Full Text] [Related]
9. Anti-melanoma antibodies bind preferentially to diploid metastases in immunoscintigraphy.
Pyrhönen S; Liewendahl K; Muhonen T; Laasonen A; Asko-Seljavaara S; Lindroth L; Franssila KO; Virkkunen P; Brownell AL
Nucl Med Commun; 1990 Sep; 11(9):597-605. PubMed ID: 2234695
[TBL] [Abstract][Full Text] [Related]
10. [Immunoscintigraphic detection of metastasis in malignant melanoma in the head and neck area].
Rosanowski F; Briele B; Walther EK
Laryngorhinootologie; 1994 Feb; 73(2):94-7. PubMed ID: 8161416
[TBL] [Abstract][Full Text] [Related]
11. Is 18F-FDG PET more accurate than standard diagnostic procedures in the detection of suspected recurrent melanoma?
Fuster D; Chiang S; Johnson G; Schuchter LM; Zhuang H; Alavi A
J Nucl Med; 2004 Aug; 45(8):1323-7. PubMed ID: 15299056
[TBL] [Abstract][Full Text] [Related]
12. [Immunoscintigraphy of malignant melanoma].
Nicol L; Sandron A; Herry JY; Chevrant-Breton J
Pathol Biol (Paris); 1990 Oct; 38(8):866-9. PubMed ID: 2274393
[TBL] [Abstract][Full Text] [Related]
13. Two phase scintigraphic mapping of lymphatic drainage in cutaneous melanoma using 99mTc-sulfur microcolloid/99mTc antimelanoma antibody.
Limouris GS; Voliotopoulos V; Kondi-Paphiti A; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1667-9. PubMed ID: 9179215
[TBL] [Abstract][Full Text] [Related]
14. Contribution of whole body F-18-FDG-PET and lymphoscintigraphy to the assessment of regional and distant metastases in cutaneous malignant melanoma. A pilot study.
Klein M; Freedman N; Lotem M; Marciano R; Moshe S; Gimon Z; Chisin R
Nuklearmedizin; 2000; 39(3):56-61. PubMed ID: 10834191
[TBL] [Abstract][Full Text] [Related]
15. Which kinds of lymph node metastases can FDG PET detect? A clinical study in melanoma.
Crippa F; Leutner M; Belli F; Gallino F; Greco M; Pilotti S; Cascinelli N; Bombardieri E
J Nucl Med; 2000 Sep; 41(9):1491-4. PubMed ID: 10994727
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma.
Blend MJ; Hyun H; Patel B; Sullivan K; Salk D
J Nucl Med; 1996 Feb; 37(2):252-7. PubMed ID: 8667055
[TBL] [Abstract][Full Text] [Related]
17. The sonographic appearance of metastatic malignant melanoma.
Paling MR; Shawker TH; Love IL
J Ultrasound Med; 1982 Mar; 1(2):75-8. PubMed ID: 6152930
[TBL] [Abstract][Full Text] [Related]
18. Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma.
Böni R; Huch Böni RA; Steinert H; Dummer R; Burg G; von Schulthess GK
Dermatology; 1995; 191(2):119-23. PubMed ID: 8520057
[TBL] [Abstract][Full Text] [Related]
19. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
[TBL] [Abstract][Full Text] [Related]
20. [Sentinel node diagnostics in malignant melanoma].
Eigtved AI; Krag ML; Dahlstrøm KK; Juhl BR; Christensen TB
Ugeskr Laeger; 1999 Apr; 161(16):2373-5. PubMed ID: 10235044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
